Gemcitabine and the interaction with anticoagulants.
Kilgour-Christie
Jean
J
Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH,., Surrey, UK
Czarnecki
Andrzej
A
D000925:Anticoagulants / Q000008:administration & dosage*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic; D012042:Registries; D018570:Risk Assessment; D014859:Warfarin / Q000008:administration & dosage*; D000093542:Gemcitabine
D000925:Anticoagulants; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D014859:Warfarin; D000093542:Gemcitabine